MFSD2A and Cerebral ischemia: Recent studies have revealed that storax-induced attenuation of BBB impairment, which helps to halt the progression of cerebral ischemia [75], occurs through the upregulation of Mfsd2a and concurrent inhibition of Cav-1 in the endothelial cells.